Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;7(6):403-412.
doi: 10.1159/000489575. Epub 2018 Jul 4.

Direct Thrombectomy versus Bridging for Patients with Emergent Large-Vessel Occlusions

Affiliations

Direct Thrombectomy versus Bridging for Patients with Emergent Large-Vessel Occlusions

Ronen R Leker et al. Interv Neurol. 2018 Oct.

Abstract

Background and aims: Patients with emergent large-vessel occlusion (ELVO) that present earlier than 4 h from onset are usually treated with bridging systemic thrombolysis followed by endovascular thrombectomy (EVT). Whether direct EVT (dEVT) could improve the chances of favorable outcome remains unknown.

Methods: Consecutively, prospectively enrolled patients with ELVO presenting within 4 h of onset were entered into a National Acute Stroke Registry of patients undergoing revascularization. Patients treated with bridging were compared to those treated with dEVT. Excellent outcome was defined as having a modified Rankin Scale score ≤1 at 90 days following stroke.

Results: Out of 392 patients that underwent thrombectomy, 270 (68%) presented within 4 h and were included. Of those, 159 (59%) underwent bridging and 111 (41%) underwent dEVT. Atrial fibrillation and congestive heart failure were more common in the dEVT group (43 vs. 30%, p = 0.04 and 20 vs. 8%, p = 0.009, respectively), but other risk factors, demographics, stroke severity and subtypes as well as baseline vessel patency state and time metrics did not differ. Excellent target vessel recanalization defined as TICI 3 (thrombolysis in cerebral infarction score) was more common in the dEVT group (75 vs. 61%, p = 0.03), but in-hospital mortality, discharge destinations, short- and long-term excellent outcome rates did not differ. On multivariate regression analysis, treatment modality did not significantly modify the chances of excellent outcome at discharge (OR 0.7; 95% CI 0.3-1.5) or at 3 months (OR 0.78 95% CI 0.4-1.4).

Conclusions: The chances of attaining excellent functional outcomes are similar in ELVO patients undergoing dEVT or bridging.

Keywords: Endovascular treatment; Reperfusion; Stentriever; Stroke; Thrombolysis.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Distribution of patients treated with EVT in the NASIS-REVASC.
Fig. 2.
Fig. 2.
Distributions of different mRS categories in patients treated with bridging or dEVT in the NASIS-REVASC.
Fig. 3.
Fig. 3.
Odds ratios for factors included in the multivariate analyses for mRS scores 0–1 at 3 months following stroke (a), in-hospital mortality (b), favorable target vessel recanalization (TICI 3) at the end of EVT (c), and major early recovery defined as an 8-point drop in NIHSS or NIHSS 0–1 on day 1 following procedure (d).

References

    1. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. “Malignant” middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309–315. - PubMed
    1. Christou I, Felberg RA, Demchuk AM, Burgin WS, Malkoff M, Grotta JC, Alexandrov AV. Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion. J Neuroimaging. 2002;12:119–123. - PubMed
    1. Derex L, Hermier M, Adeleine P, Pialat JB, Wiart M, Berthezene Y, Froment JC, Trouillas P, Nighoghossian N. Influence of the site of arterial occlusion on multiple baseline hemodynamic MRI parameters and post-thrombolytic recanalization in acute stroke. Neuroradiology. 2004;46:883–887. - PubMed
    1. Lee KY, Han SW, Kim SH, Nam HS, Ahn SW, Kim DJ, Seo SH, Kim DI, Heo JH. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke. 2007;38:192–193. - PubMed
    1. Linfante I, Llinas RH, Selim M, Chaves C, Kumar S, Parker RA, Caplan LR, Schlaug G. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator. Stroke. 2002;33:2066–2071. - PubMed